/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Brad Jones

Brad Jones

Staff Writer

Latest Stories

Futurism
Updated 3.6.18, 5:47 PM EST on futurism
Three Things You Need to Know About Google's New Quantum Processor
Futurism
Updated 3.6.18, 5:39 PM EST on futurism
Amazon Takes Photographic Proof of Delivery. What Could Go Wrong?
Futurism
3.6.18, 5:03 PM EST on neoscope
Australia May Soon Eliminate Cervical Cancer
Futurism
3.6.18, 3:27 PM EST on neoscope
Exploring Animals' "Junk DNA" Could Help Us Fight Human Diseases
Futurism
Updated 3.6.18, 9:23 AM EST on neoscope
A New Chemical Treatment Could Make Water Safe to Drink for Months
Futurism
3.5.18, 12:24 PM EST on futurism
AI Predicts Coding Mistakes Before Developers Make Them
Futurism
3.2.18, 3:52 PM EST on futurism
4 Astounding Things About Russia's (Supposed) New Weapons
Futurism
3.2.18, 3:06 PM EST on neoscope
To Cure a Deadly Disease, 17 People Will Be Knowingly Infected With Worms
Futurism
Updated 3.2.18, 2:01 PM EST on futurism
EU to Internet Companies: You Have Three Months to Get Rid of Extremist Content
Futurism
3.1.18, 5:52 PM EST on futurism
What Does It Take to Drive a Laser Cross-Country? A Lot, It Turns Out.
Futurism
3.1.18, 2:35 PM EST on futurism
Which Electric Sports Car Is Right for You, Porsche or Tesla?
Futurism
Updated 3.1.18, 1:13 PM EST on neoscope
An Osteoarthritis Drug May Be the Answer to America's Opioid Crisis
  • Previous
  • 1
  • ...
  • 36
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.